• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agency of Health Technology Assessment of Uruguay
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Healthcare Quality Institute
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [25177 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2025     Agencia de Evaluacion de Tecnologias Sanitarias (AETS-ISCIII) [Efficacy and safety of selective posterior nasal nerve cryosurgery for the symptomatic treatment of chronic rhinosinusitis]
2025     Andalusian Health Technology Assessment Area (AETSA) [Efficacy and safety of ex vivo perfusion to assess and prepare lungs for transplantations]
2025     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Effectiveness, safety, and cost-effectiveness of prenatal serological screening for cytomegalovirus]
2025     Agency for Healthcare Research and Quality (AHRQ) Updating the framework for the Agency for Healthcare Research and Quality's National Healthcare Quality and Disparities Report
2025     Agency for Healthcare Research and Quality (AHRQ) Trauma informed care: a systematic review
2025     Agency for Healthcare Research and Quality (AHRQ) Supply chain disruption monitoring programs
2025     Agency for Healthcare Research and Quality (AHRQ) Psychosocial and pharmacologic interventions for disruptive behavior in children and adolescents
2025     Agency for Healthcare Research and Quality (AHRQ) Pharmacologic and nonpharmacologic treatments for posttraumatic stress disorder: an update of the PTSD trials standardized repository
2025     Agency for Healthcare Research and Quality (AHRQ) Peripheral nerve blocks for postoperative pain management in cardiothoracic surgery: a systematic review
2025     Agency for Healthcare Research and Quality (AHRQ) Pediatric Quality Measures Program 3.0: an evidence map of measures for vision, hearing, and developmental screening and followup
2025     Agency for Healthcare Research and Quality (AHRQ) Misuse of ADHD prescription stimulants in adults
2025     Agency for Healthcare Research and Quality (AHRQ) Mental health and occupational stress in the emergency medical services and 911 workforces
2025     Agency for Healthcare Research and Quality (AHRQ) Measure criteria for the Agency for Healthcare Research and Quality's National Healthcare Quality and Disparities Report
2025     Agency for Healthcare Research and Quality (AHRQ) Management of suicidal thoughts and behaviors in youth: a systematic review
2025     Agency for Healthcare Research and Quality (AHRQ) Making healthcare safer IV: use of structured handoff protocols for intrahospital within-unit transitions
2025     Agency for Healthcare Research and Quality (AHRQ) Making healthcare safer IV: programs for responding to harms experienced by patients during clinical care
2025     Agency for Healthcare Research and Quality (AHRQ) Living systematic review on cannabis and other plant-based treatments for chronic pain
2025     Agency for Healthcare Research and Quality (AHRQ) Interventions to prevent nonventilator hospital-acquired pneumonia
2025     Agency for Healthcare Research and Quality (AHRQ) Interventions to improve care of bereaved persons
2025     Agency for Healthcare Research and Quality (AHRQ) Implementing recommended mental health and substance use screening and counseling interventions in primary care settings for children and adolescents
2025     Agency for Healthcare Research and Quality (AHRQ) Fiber intake and laxation in people with normal bowel function
2025     Agency for Healthcare Research and Quality (AHRQ) Examining the impact of implementing high-reliability organization principles on patient safety outcomes
2025     Agency for Healthcare Research and Quality (AHRQ) Digestible carbohydrate intake and maternal-infant outcomes: a systematic review
2025     Agency for Healthcare Research and Quality (AHRQ) Comparative effectiveness of medical therapies for locally advanced gastric adenocarcinoma
2025     Agency for Healthcare Research and Quality (AHRQ) Breastfeeding and health outcomes for infants and children
2025     Agency for Healthcare Research and Quality (AHRQ) Blood-based tests for multiple cancer screening: a systematic review
2025     Agency for Healthcare Research and Quality (AHRQ) Association of digestible carbohydrate intake with cardiovascular disease, type 2 diabetes, obesity, and body composition
2025     Agency for Healthcare Research and Quality (AHRQ) Association between outcomes and dental services in people with substance use disorder: a rapid response review
2025     Agency for Healthcare Research and Quality (AHRQ) Association between outcomes and dental services in people receiving treatments that cause medication-related osteonecrosis of the jaw: a rapid response review
2025     Agency for Healthcare Research and Quality (AHRQ) Association between outcomes and dental services in people receiving treatment for human immunodeficiency virus: a rapid response review
2025     Agency for Healthcare Research and Quality (AHRQ) Association between outcomes and dental services in people at risk of post-transplant complications: a rapid response review
2025     Agency for Healthcare Research and Quality (AHRQ) Assisted home dialysis in the United States: new interest in an old idea
2025     Agency for Healthcare Research and Quality (AHRQ) Acute care nursing staff shortages that compromise patient-to-nurse ratios
2025     Center for Drug Evaluation (CDE) [HTA Rapid report- Rinvoq 45 mg, 15 mg (Crohn's disease, ulcerative colitis)]
2025     Center for Drug Evaluation (CDE) [HTA Rapid report- Mesh fixation device (laparoscopic inguinal hernia repair)]
2025     Center for Drug Evaluation (CDE) [HTA Rapid report- Drug-eluting beads]
2025     Center for Drug Evaluation (CDE) [HTA Rapid report- Darzalex (multiple myeloma with ASCT)]
2025     Center for Drug Evaluation (CDE) [HTA Rapid report- Cabometyx 20, 40, 60 mg (advanced or metastatic differentiated thyroid cancer)]
2025     Austrian Institute for Health Technology Assessment (AIHTA) Long-term effectiveness and safety of enzyme replacement therapy in mucopolysaccharidosis type I, II, IVA and Pompe disease: a systematic review
2025     Austrian Institute for Health Technology Assessment (AIHTA) Dorocubicel + unexpanded CD34– cells (Zemcelpro®) for the treatment of haematological malignancies in adults
2025     WorkSafeBC Effect of ropinirole on patients with myoclonic dystonia: 2025 update
2025     WorkSafeBC Osteoarthritis of the knee and foot orthoses
2025     WorkSafeBC Cervical disc herniation and cervical spine degeneration
2025     WorkSafeBC COVID-19 vaccine and systemic lupus erythematosus (SLE)
2025     WorkSafeBC Use of supplements to treat patients diagnosed with sciatica
2025     WorkSafeBC Firefighting and Hodgkins lymphoma
2025     WorkSafeBC Hypertension and firefighting
2025     WorkSafeBC Platelet rich plasma (PRP) in treating post-fracture ankle pain
2025     WorkSafeBC External trigeminal nerve stimulation (e-TNS) in treating and preventing migraine headaches
2025     Agency for Care Effectiveness (ACE) Toripalimab for first-line systemic treatment of recurrent or metastatic nasopharyngeal carcinoma
2025     Agency for Care Effectiveness (ACE) Momelotinib for treating myelofibrosis in patients with moderate to severe anaemia
2025     Agency for Care Effectiveness (ACE) Datopotamab deruxtecan for previously treated unresectable or metastatic HR-positive, HER2-negative breast cancer
2025     Agency for Care Effectiveness (ACE) Onasemnogene abeparvovec for treating spinal muscular atrophy
2025     Agency for Care Effectiveness (ACE) Sotorasib for previously treated KRAS G12C-mutated locally advanced or metastatic non-small-cell lung cancer
2025     Agency for Care Effectiveness (ACE) Sucroferric oxyhydroxide for treating hyperphosphataemia in patients with end-stage renal disease on dialysis
2025     Agency for Care Effectiveness (ACE) Talazoparib in combination with enzalutamide for treating HRR gene-mutated metastatic castration-resistant prostate cancer
2025     Agency for Care Effectiveness (ACE) Durvalumab with or without olaparib for treating primary advanced or recurrent endometrial cancer
2025     Agency for Care Effectiveness (ACE) Tislelizumab for treating locally advanced or metastatic non-squamous non-small-cell lung cancer without EGFR or ALK genomic tumour aberrations
2025     NIHR Health Technology Assessment programme Clinical and cost-effectiveness of technologies for the assessment of attention deficit hyperactivity disorder: a systematic review and economic model
2025     Scottish Health Technologies Group (SHTG) Digital prevention programmes for people at risk of developing type 2 diabetes
2025     Scottish Health Technologies Group (SHTG) Electrocardiogram (ECG) patch monitors for the detection of cardiac rhythm abnormalities
2025     Scottish Health Technologies Group (SHTG) Home blood pressure monitoring for people with suspected or confirmed hypertension
2025     Canary Health Service [Effectiveness, safety and cost-effectiveness of neonatal screening for familial hypercholesterolemia]
2025     Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Therapeutic use of blankets, vests and other weighted objects with different clienteles]
2025     Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Effectiveness of mental health outreach services for adolescent clientele: modalities and approaches in a context of scarce resources]
2025     Haute Autorite de sante (HAS) [Appropriateness of prescribing erythrocyte sedimentation rate (ESR) – are there any remaining?]
2025     Basque Office for Health Technology Assessment (OSTEBA) [Hybrid operating rooms]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Mirdametinib (neurofibromatosis type 1) – Assessment according to §35a (para. 1, sentence 11) Social Code Book V]
2025     Agency for Care Effectiveness (ACE) Hydrogel rectal spacers for rectum protection during radiation therapy for prostate cancer
2025     Agency for Care Effectiveness (ACE) Advanced hybrid closed loop system for people with type 1 diabetes mellitus
2025     Agency for Care Effectiveness (ACE) Intraoperative cell salvage for surgeries with anticipated or possible significant blood loss
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Durvalumab (urothelial carcinoma) – Addendum to Project A25-97]
2025     Agency for Care Effectiveness (ACE) Biomarker-based brain trauma assessment tests to aid in the evaluation of mild traumatic brain injury in adults
2025     Agency for Care Effectiveness (ACE) Portable Neuromodulation Stimulator (PoNS) for treating gait deficit due to multiple sclerosis
2025     Agency for Care Effectiveness (ACE) LumiSystem for intraoperative tumour margin assessment following breast-conserving surgery
2025     Agency for Care Effectiveness (ACE) Edison Histotripsy System for non-invasive destruction of liver tumours
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Securing scientific research without PubMed and ClinicalTrials.gov]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sepiapterin (phenylketonuria) – Addendum to Project G25-23]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ixekizumab (enthesitis-related arthritis) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Trastuzumab deruxtecan (gastric or gastroesophageal junction adenocarcinoma) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Linvoseltamab (multiple myeloma) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concizumab (haemophilia B) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concizumab (haemophilia A) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tislelizumab (NSCLC, neoadjuvant + adjuvant) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ixekizumab (juvenile psoriatic arthritis) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tislelizumab (nasopharyngeal carcinoma) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tislelizumab (small cell lung cancer, extensive stage) – Benefit assessment according to §35a Social Code Book V]
2025     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Evaluation of the safety and efficacy of guided imagery for the control of chronic pain]
2025     Basque Office for Health Technology Assessment (OSTEBA) [CT-guided percutaneous ablation for lung metastasis using radiofrequency or microwaves in patients who are not eligible for curative local and/ or systemic treatment]
2025     Basque Office for Health Technology Assessment (OSTEBA) [Magnetic nanoparticles and a magnetic field generator for inducing hyperthermia in the treatment of pancreatic cancer]
2025     Basque Office for Health Technology Assessment (OSTEBA) [Efficacy and safety of non-invasive brain stimulation therapies for the neurorehabilitation of patients with stroke]
2025     Basque Office for Health Technology Assessment (OSTEBA) [Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of children with peritoneal carcinomatosis]
2025     Basque Office for Health Technology Assessment (OSTEBA) [Effectiveness and safety of adaptive radiation therapy in patients with lymphoma, head and neck cancer or lung carcinoma]
2025     Basque Office for Health Technology Assessment (OSTEBA) [Intrasaccular device for endovascular treatment of cerebral aneurysm]
2025     Basque Office for Health Technology Assessment (OSTEBA) [Intraoperative fluorescence imaging for cancer cell identification]
2025     Basque Office for Health Technology Assessment (OSTEBA) [Cardiovascular monitoring systems using photoplethysmography]
2025     Basque Office for Health Technology Assessment (OSTEBA) [Intestinal ultrasound in inflammatory bowel disease: diagnostic effectiveness, cost-effectiveness and patient and health professional perspectives]
2025     Basque Office for Health Technology Assessment (OSTEBA) [3D printing in traumatology, cardiology, vascular surgery, maxillofacial surgery, neurosurgery, joint injuries, and bone repair]
2025     Agenzia nazionale per i servizi sanitari regionali (Agenas) Robotic surgery systems in general surgery, gynecology, and urology
2025     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Evaluation of extending population-based breast cancer screening to women aged 45–49 and 70–74 and the use of digital breast tomosynthesis in screening women with dense breast tissue]